Search

Search Results

• THERAPEUTIC OPTIONS FOR PATIENTS WHO ARE NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY

  Elihu Estey

  e2013050

  2013-07-12

  https://doi.org/10.4084/mjhid.2013.050

  2227

  PDF: 771

  HTML: 1639

• TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS

  Luca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, Chiara Sarlo, Luigi Di Caprio, Concetta Ditto, Federica Giannotti, Daniela Nasso, Eleonora Ceresoli, Massimiliano Postorino, Marco Refrigeri, Sergio Amadori, Adriano Venditti

  e2013032

  2013-06-03

  https://doi.org/10.4084/mjhid.2013.032

  2897

  PDF: 1043

  HTML: 5631

• The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients

  Hesham Elsabah, Mahmood B. Aldabt, Ruba Taha, Dina Sameh Soliman, Halima Elomri, Feryal Ibrahim

  e2020082

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.082

  1049

  PDF: 386

  HTML: 239

• Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation (autoHSCT)

  Serdar Sivgin

  e2013006

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.006

  1192

  PDF: 650

  HTML: 3341

• ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME

  Teresa L Field, Claudio Anasetti

  e2010019

  2010-07-19

  https://doi.org/10.4084/mjhid.2010.019

  1392

  PDF: 692

  HTML: 1247

• COVID-19 post hematopoietic cell transplant, a report of 11 cases from a single center.

  Afadil Adam

  e2020070

  2020-08-29

  https://doi.org/10.4084/mjhid.2020.070

  1777

  PDF: 1157

  HTML: 329

• REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Giovanni D'arena, Giovanni Rossi, Barbara Vannata, Silvia Deaglio

  e2012053

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.053

  2384

  PDF: 1027

  HTML: 7691

  Untitled: 295

  Fig2: 196

  Fig3: 192

  Fig4: 201

• IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.

  Jean Elcheikh

  e2013026

  2013-04-10

  https://doi.org/10.4084/mjhid.2013.026

  1341

  PDF: 762

  HTML: 1481

• WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

  Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi

  e2018004

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.004

  7774

  PDF: 2468

  HTML: 2104

  Table 1.: 237

  Table 2.: 247

  Table 3.: 230

  Table 4.: 223

• Multiple myeloma diagnosed by CT-guided rib biopsy after a hemodilute bone marrow aspirate, in a patient with a biclonal pattern on serum protein electrophoresis Multiple Myeloma diagnosed with CT-guided rib biopsy

  Arjeta Cyrbja, Liri Seraj, Shaqir Qerama

  e2026061

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.061

  211

  PDF: 99

  HTML: 171

• EARLY APPLICATION OF HIGH CUT-OFF HAEMODYALISIS FOR DE-NOVO MYELOMA NEPHROPATHY IS ASSOCIATED WITH LONG-TERM DIALYSIS-INDEPENDENCY AND RENAL RECOVERY

  Alhossain A. Khalafallah, Sie Wuong Loi, Sarah Love, Muhajir B. Mohamed, Rose Mace, Ramy Khalil, Miriam Girgs, Rajesh Raj, Mathew Mathew

  e2013007

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.007

  1410

  PDF: 680

  HTML: 2543

  cover letter: 211

• TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo

  e2025039

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.039

  2450

  PDF: 1699

  HTML: 458

• NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?

  Alessandro Corso, Silvia Mangiacavalli

  e2017053

  2017-08-18

  https://doi.org/10.4084/mjhid.2017.053

  3336

  PDF: 1736

  HTML: 1149

• CLASSIC KSHV/HHV-8-POSITIVE PRIMARY EFFUSION LYMPHOMA (PEL): A SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE REPORTS

  Ilaria Cozzi, Giovanni Rossi, Emma Rullo, Valeria Ascoli

  e2022020

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.020

  1626

  PDF: 996

  HTML: 422

• Impact of daratumumab on stem cell mobilization and transplant in patient with newly diagnosed multiple myeloma: a real word single-center study

  Mauro Passucci, Francesca Fazio, Jacopo Micozzi, Manhaz Shafii Bafti, Giovanni Manfredi Assanto, Alfonso Piciocchi, Maurizio Martelli, Maria Teresa Petrucci

  e2024041

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.041

  1294

  PDF: 1085

  Suppl. Files: 723

  HTML: 84

• HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

  Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré

  e2014050

  2014-07-01

  https://doi.org/10.4084/mjhid.2014.050

  2977

  PDF: 1399

  HTML: 3719

  Untitled: 208

  Untitled: 221

  Untitled: 195

• CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma

  Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone

  e2024012

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.012

  2425

  PDF: 1889

  HTML: 159

• QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION

  Alhossain A. Khalafallah, Kristina McDonnell, Hizb U. Dawar, Iain Robertson, David Woods

  e2011057

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.057

  1442

  PDF: 712

  HTML: 1384

  cover letter: 222

• ASSOCIATION BETWEEN LEUKEMIC EVOLUTION AND UNCOMMON CHROMOSOMAL ALTERATIONS IN PEDIATRIC MYELODYSPLASTIC SYNDROME

  Viviane Lamim Lovatel, Beatriz Ferreira da Silva , Eliane Ferreira Rodrigues , Maria Luiza Rocha da Rosa Borges , Rita de Cássia Barbosa Tavares, Ana Paula Silva Bueno, Elaine Sobral da Costa, Terezinha de Jesus Marques , Teresa de Souza Fernandez

  e2024003

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.003

  1254

  PDF: 1412

  HTML: 138

• Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs

  Feiying Meng

  e2021041

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.041

  1177

  PDF: 528

  HTML: 381

• EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

  Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca

  e2024042

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.042

  4544

  PDF: 1759

  HTML: 1172

• DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

  Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso

  e2022030

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.030

  1447

  HTML: 630

  PDF: 866

• CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment

  Ugo Testa, Elvira Pelosi, Dr. Germana Castelli

  e2024077

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.077

  1806

  PDF: 885

  HTML: 1148

• COMPREHENSIVE REVIEW OF GENETIC AND EPIGENETICS REGULATION OF FETAL HEMOGLOBIN IN β-HEMOGLOBINOPATHIES: FROM MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS HbF Genetics in Anemia

  Yousef Saeed Mohammad Abu Za’ror, Joseph Bagi Suleiman, Fatima Azzahra Delmani, Jehad Farouq Alhmoud, Amer Mohammad Ayasreh, Sarah Ihsan Al-wendawi, Maryam Azlan

  e2026046

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.046

  704

  PDF: 569

  HTML: 74

• COVID-19 induces prolonged immunological exhaustion leading to relapse of hematological malignancies except in hematopoietic cell transplant recipients

  SUPARNO CHAKRABARTI, Snigdha Banerjee, Mahak Agarwal, Gitali Bhagawati, Nilanjan Saha, SARITA JAISWAL

  e2025042

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.042

  1086

  PDF: 787

  HTML: 144

• REAL WORLD MULTIPLE MYELOMA REGISTRY FROM JORDAN, A DEVELOPING COUNTRY.

  Abdalla Awidi, Farah Qasem, A'sem Abu-Qamar, Batool Aqel, Rand Aladayleh, Ilham Alteerah, Ahmad Magableh, , Hisham Bawa”neh, Feras Al-fararjeh

  e2022031

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.031

  1358

  PDF: 777

  HTML: 413

• POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

  Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles

  e2010016

  2010-06-19

  https://doi.org/10.4084/mjhid.2010.016

  1212

  PDF: 787

  HTML: 588

• OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT

  Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst

  e2023025

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.025

  1414

  HTML: 384

  PDF: 982

  Suppl. Files: 483

• FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

  Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo

  e2024029

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.029

  1020

  PDF: 1246

  HTML: 123

• A POPULATION-BASED STUDY ON MYELODYSPLASTIC SYNDROMES IN THE LAZIO REGION (ITALY), MEDICAL MISCODING AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY

  Flavia Mayer, Laura Faglioni, Nera Agabiti, Susanna Fenu, Francesco Buccisano, Roberto Latagliata, Roberto Ricci, Maria Antonietta Aloe Spiriti, Caterina Tatarelli, Massimo Breccia, Giuseppe Cimino, Luana Fianchi, Svitlana Gumenyuk, Stefano Mancini, Luca Maurillo, Carolina Nobile, Pasquale Niscola, Anna Lina Piccioni, Agostino Tafuri, Giulio Trapè, Alessandro Andriani, Paolo De Fabritis, Maria Teresa Voso, Marina Davoli, Gina Zini

  e2017046

  2017-07-01

  https://doi.org/10.4084/mjhid.2017.046

  2770

  PDF: 1032

  HTML: 1161

• CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH

  Lisa Pieri, Paola Guglielmelli, Alessandro Maria Vannucchi

  e2010017

  2010-06-18

  https://doi.org/10.4084/mjhid.2010.017

  1747

  PDF: 765

  HTML: 2349

• Zanubrutinib as upfront treatment in de-novo B-cell prolymphocytic leukemia: the case of two elderlies.

  Silvia Giorgi, Giovanna Leonardi, Monica Maccaferri, Elena Sbadili, Carlo Caterina, Giovanni Fera, Ambra Paolini, Leonardo Potenza, Anna Candoni, Mario Luppi, Roberto Marasca

  e2025061

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.061

  1345

  PDF: 595

  Html: 234

• TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1

  PIMJAI NIPARUCK

  e2021063

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.063

  1229

  PDF: 576

  HTML: 247

• A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab

  Mauro Passucci, Francesca Fazio, Maria Teresa Petrucci

  e2023012

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.012

  1048

  PDF: 979

  HTML: 419

• Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma

  Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti

  e2025051

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.051

  783

  PDF: 607

  HTML: 49

• Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells

  Dina Sameh Soliman, Hesham Elsabah, Ibrahim Ganwo, Aliaa Amer, Ruba Y Taha, Lajos Szabados , Mouhammad Sharaf Eldean, Ahmad Al-Sabbagh, Feryal Ibrahim

  e2021043

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.043

  1942

  PDF: 434

  HTML: 226

• Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy

  Gianluca Cavallaro

  e2024049

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.049

  2266

  HTML: 149

  PDF: 1170

• CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

  Luca Castagna, Carmelo Carlo-Stella, Rita Mazza, Armando Santoro

  e2015015

  2015-02-12

  https://doi.org/10.4084/mjhid.2015.015

  2857

  PDF: 1443

  HTML: 4669

• Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease

  Giacomo Andreani, Gianluca Fadda, Dario Gned, Matteo Dragani, Giovanni Cavallo, Valentina Monticone, Alessandro Morotti, Marco De Gobbi, Angelo Guerrasio, Antonio D'Avolio, Daniela Cilloni

  e2019061

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.061

  1481

  PDF: 1122

  HTML: 230